Mandate

Vinge advises Edgeware AB (publ) in connection with listing on Nasdaq Stockholm

December 14, 2016

 Vinge has advised Edgeware AB (publ) (“Edgeware”) in connection with its listing on Nasdaq Stockholm. The prospectus was published on 29 November 2016 and the first day of trading on Nasdaq was 9 December 2016. The offer price was set at SEK 29 per share, which corresponded to a market value for the total number of shares in the company of approximately MSEK 870. The total value of the offering amounted to MSEK 450 provided an overallotment option was exercised in its entirety.
 
Edgeware was founded in 2004 and has since evolved into a global, high-tech company that develops and offers hardware and software systems as well as associated services that enable effective and scalable TV and video streaming over IP. The Company’s solutions are primarily sold to telecom and cable operators as well as broadcasters and content owners that want to efficiently, securely and cost-efficiently make TV and video content available to their viewers.
 
Vinge’s team primarily consisted of Johan Larsson, Jesper Schönbeck, Rikard Lindahl, Johan Mattson, Amanda Knutsson, Malte Hedlund and Michaela Cronemyr. Tora Hansjons, Emilie Parland and Maria Schultzberg advised on tax issues.

Related

Vinge advises Sobro on its investment in Västkustens Konstruktionsbyrå

Västkustens Konstruktionsbyrå has decided to broaden its ownership structure by bringing in Sobro as a new co-partner and majority shareholder. The founders will remain with the company as the CEO and CTO respectively, and as significant shareholders. Västkustens Konstruktionsbyrå is an engineering consultancy company based in Gothenburg with cutting-edge expertise in project management, civil engineering and design.
April 23, 2026

Vinge has advised Egetis Therapeutics in connection with a directed share issue

Vinge has advised Egetis Therapeutics AB (publ) (“Egetis Therapeutics”), listed on Nasdaq Stockholm, in connection with a directed share issue whereby Egetis Therapeutics raised proceeds of SEK 350 million before transaction costs.
April 22, 2026

Vinge has advised Alder on the establishment of Alder Strategic Opportunities Fund I and on a fund credit facility agreement in connection with the fundraising

Vinge has advised Alder on the establishment of the continuation fund Alder Strategic Opportunities Fund I AB. In connection with the establishment, the fund acquires the portfolio companies SI and SMG from Alder II. Vinge also advised Alder on the entering into of a fund credit facility agreement with SEB.
April 20, 2026